Novel Azaborine Derivatives Predicted to Eliminate Acetaminophen Hepatotoxicity
新型氮杂硼啉衍生物有望消除对乙酰氨基酚的肝毒性
基本信息
- 批准号:8195745
- 负责人:
- 金额:$ 25.44万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2011
- 资助国家:美国
- 起止时间:2011-09-26 至 2013-12-05
- 项目状态:已结题
- 来源:
- 关键词:Accident and Emergency departmentAccountingAcetaminophenAcute Liver FailureBiologicalBiological TestingBoronCell RespirationCessation of lifeDoseDrug KineticsDrug usageEvaluationEventExhibitsFeverGoalsHepatotoxicityHuman Cell LineHypersensitivityIn VitroInvestigationLiverLiver FailureMetabolicMethodsN-acetyl-4-benzoquinoneimineNamesNitrogenOverdosePainPair BondPharmaceutical PreparationsPhasePhenacetinPoisoningPropertyScheduleSchemeSmall Business Technology Transfer ResearchTask PerformancesTherapeutic IndexToxic effectTylenolVisitacetaminophen overdoseanalogbasecytotoxiccytotoxicitydesigndosagedrug candidatein vitro testingnovelphase 2 studyresearch study
项目摘要
DESCRIPTION (provided by applicant): Overdose on acetaminophen (more commonly known by the brand name Tylenol(R)), accounts for 56,000 emergency room visits and more than 450 deaths annually in the USA. Acetaminophen overdose can occur by a single event of exceeding the recommended daily dosage. Overdose on acetaminophen is facilitated by the fact that it is a common ingredient in over-the-counter medications for cold, allergies, and congestion, conditions for which people often take multiple medications. The hepatotoxicity of acetaminophen is due to N-acetyl-p- benzoquinoneimine (NAPQI), which is generated by oxidative metabolism. Proposed herein are new 1,2-azaborines, wherein a CC bond pair of an arene is replaced with an isosteric boron- nitrogen unit that is designed to eliminate the formation of the toxic metabolite. This proposal seeks to: 1) synthesize novel 1,2-azaborine-based derivatives of acetaminophen, 2) determine their cytotoxicity and pharmacokinetics via appropriate in vitro tests, and 3) identify compounds to be studied in a Phase II STTR application.
PUBLIC HEALTH RELEVANCE: Novel Azaborine Derivatives Predicted to Eliminate Acetaminophen Hepatotoxicity Overdose on acetaminophen (more commonly known by the brand name Tylenol(R)), accounts for 56,000 emergency room visits and more than 450 deaths annually in the USA. The toxicity of acetaminophen to the liver is due to a metabolic by-product. Proposed herein are new boron-nitrogen-containing analogues of acetaminophen that are designed to eliminate the formation of that metabolic by-product.
描述(由申请人提供):过量服用对乙酰氨基酚(通常以品牌名称泰诺(R)而闻名),在美国每年造成56,000次急诊室就诊和450多人死亡。对乙酰氨基酚过量可由超过每日推荐剂量的单一事件引起。对乙酰氨基酚是治疗感冒、过敏和充血的非处方药物中的一种常见成分,这一事实助长了对乙酰氨基酚的过量使用,而人们通常会服用多种药物。对乙酰氨基酚的肝毒性是由氧化代谢产生的n -乙酰基对苯醌亚胺(NAPQI)引起的。本文提出了一种新的1,2-氮杂aborines,其中芳烃的CC键对被等构硼氮单元取代,旨在消除有毒代谢物的形成。本提案旨在:1)合成新型的1,2-氮杂波碱对乙酰氨基酚衍生物,2)通过适当的体外试验确定其细胞毒性和药代动力学,以及3)确定用于II期STTR应用研究的化合物。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Shih-Yuan Liu其他文献
Shih-Yuan Liu的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Shih-Yuan Liu', 18)}}的其他基金
Novel Reagents and Catalysts for Organic Synthesis
用于有机合成的新型试剂和催化剂
- 批准号:
10387406 - 财政年份:2020
- 资助金额:
$ 25.44万 - 项目类别:
Novel Reagents and Catalysts for Organic Synthesis
用于有机合成的新型试剂和催化剂
- 批准号:
10121469 - 财政年份:2020
- 资助金额:
$ 25.44万 - 项目类别:
Novel Reagents and Catalysts for Organic Synthesis
用于有机合成的新型试剂和催化剂
- 批准号:
10455044 - 财政年份:2020
- 资助金额:
$ 25.44万 - 项目类别:
Novel Reagents and Catalysts for Organic Synthesis
用于有机合成的新型试剂和催化剂
- 批准号:
10663272 - 财政年份:2020
- 资助金额:
$ 25.44万 - 项目类别:
Novel Reagents and Catalysts for Organic Synthesis
用于有机合成的新型试剂和催化剂
- 批准号:
10263287 - 财政年份:2020
- 资助金额:
$ 25.44万 - 项目类别:
Development of BN Heterocycles for Biomedical Research
用于生物医学研究的氮化硼杂环化合物的开发
- 批准号:
8518381 - 财政年份:2010
- 资助金额:
$ 25.44万 - 项目类别:
Development of BN Heterocycles for Biomedical Research
用于生物医学研究的氮化硼杂环化合物的开发
- 批准号:
7949958 - 财政年份:2010
- 资助金额:
$ 25.44万 - 项目类别:
Development of BN Heterocycles for Biomedical Research
用于生物医学研究的氮化硼杂环化合物的开发
- 批准号:
9173274 - 财政年份:2010
- 资助金额:
$ 25.44万 - 项目类别:
Development of BN Heterocycles for Biomedical Research
用于生物医学研究的氮化硼杂环化合物的开发
- 批准号:
8733176 - 财政年份:2010
- 资助金额:
$ 25.44万 - 项目类别:
Development of BN Heterocycles for Biomedical Research
用于生物医学研究的氮化硼杂环化合物的开发
- 批准号:
8306276 - 财政年份:2010
- 资助金额:
$ 25.44万 - 项目类别:
相似海外基金
Unraveling the Dynamics of International Accounting: Exploring the Impact of IFRS Adoption on Firms' Financial Reporting and Business Strategies
揭示国际会计的动态:探索采用 IFRS 对公司财务报告和业务战略的影响
- 批准号:
24K16488 - 财政年份:2024
- 资助金额:
$ 25.44万 - 项目类别:
Grant-in-Aid for Early-Career Scientists
Mighty Accounting - Accountancy Automation for 1-person limited companies.
Mighty Accounting - 1 人有限公司的会计自动化。
- 批准号:
10100360 - 财政年份:2024
- 资助金额:
$ 25.44万 - 项目类别:
Collaborative R&D
Accounting for the Fall of Silver? Western exchange banking practice, 1870-1910
白银下跌的原因是什么?
- 批准号:
24K04974 - 财政年份:2024
- 资助金额:
$ 25.44万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
A New Direction in Accounting Education for IT Human Resources
IT人力资源会计教育的新方向
- 批准号:
23K01686 - 财政年份:2023
- 资助金额:
$ 25.44万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
An empirical and theoretical study of the double-accounting system in 19th-century American and British public utility companies
19世纪美国和英国公用事业公司双重会计制度的实证和理论研究
- 批准号:
23K01692 - 财政年份:2023
- 资助金额:
$ 25.44万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
An Empirical Analysis of the Value Effect: An Accounting Viewpoint
价值效应的实证分析:会计观点
- 批准号:
23K01695 - 财政年份:2023
- 资助金额:
$ 25.44万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Accounting model for improving performance on the health and productivity management
提高健康和生产力管理绩效的会计模型
- 批准号:
23K01713 - 财政年份:2023
- 资助金额:
$ 25.44万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
CPS: Medium: Making Every Drop Count: Accounting for Spatiotemporal Variability of Water Needs for Proactive Scheduling of Variable Rate Irrigation Systems
CPS:中:让每一滴水都发挥作用:考虑用水需求的时空变化,主动调度可变速率灌溉系统
- 批准号:
2312319 - 财政年份:2023
- 资助金额:
$ 25.44万 - 项目类别:
Standard Grant
New Role of Not-for-Profit Entities and Their Accounting Standards to Be Unified
非营利实体的新角色及其会计准则将统一
- 批准号:
23K01715 - 财政年份:2023
- 资助金额:
$ 25.44万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Improving Age- and Cause-Specific Under-Five Mortality Rates (ACSU5MR) by Systematically Accounting Measurement Errors to Inform Child Survival Decision Making in Low Income Countries
通过系统地核算测量误差来改善特定年龄和特定原因的五岁以下死亡率 (ACSU5MR),为低收入国家的儿童生存决策提供信息
- 批准号:
10585388 - 财政年份:2023
- 资助金额:
$ 25.44万 - 项目类别:














{{item.name}}会员




